(
344
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Exploring the AXIS communications in allergy and chronic diseases
-
Flash Talks on rhinosinusitis and nasal polyps
-
Ligelizumab in adolescent patients with chronic spontaneous urticaria: results from a dedicated phase 2b study
-
Management of Chronic Urticaria and involving the patient
-
New mechanisms for chronic diseases
-
Trichinella spiralis infection associated with chronic spontaneous urticaria – case series
-
When hives are not chronic urticaria
-
Assessing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) severity by JESREC algorithm
-
Chronic rhinosinusitis with nasal polyps
-
Endotype-driven treatment in chronic rhinosinusitis
-
Endotyping chronic rhinosinusitis for a better treatment approach
-
Novel insights into chronic rhinosinusitis with nasal polyps
-
Real-life evidence of the burden of chronic rhinosinusitis (CRS)
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
Show more Event Resources (12)Show Less-
-
Asking the right questions: From precision medicine to personalized health care in patients with refractory or unexplained chronic cough
-
Chronic spontaneous urticaria: defining the pathway to successful management
-
Complete control of chronic spontaneous urticaria – mission (im)possible?
-
Exploring the Complexity of Chronic Spontaneous Urticaria
-
How can we improve the approach to treating chronic urticaria in children?
-
Mind the PAF: a new route to managing chronic urticaria and allergic diseases?
-
Refractory Chronic Cough: A Symptom or a Disease?
Show more Sponsored Symposia (5)Show Less-
-
Distinct expression of SARS- CoV-2 receptor ACE2 correlates with endotypes of rhinosinusitis with nasal polyps
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
-
Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic – An EAACI Position Paper
-
Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitis
Show more Covid-19 (2)Show Less-
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria Taskforce
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
-
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)
-
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper
Show more Position Papers (3)Show Less-
Website
Collapse
-
“Evaluating Inflammatory Markers in Chronic Spontaneous Urticaria: Impact of Omalizumab Treatment”
-
A Comparison of Chronic Spontaneous Urticaria Presentation in Canadian and Israeli Adults
-
A Difficult to Treat Chronic Urticaria With Psychological Stress, High Anti-Thyroglobulin and De-labeling Hypersensitivity Reaction to Cetirizine
-
A case of chronic cough induced by esophageal hypersensitivity
-
A critical analysis of Chat-GPT’s replies to inquiries about chronic urticaria, focusing on the information’s reliability, accuracy, content, and readability
-
A novel approach of pooling donors for basophil testing to diagnose type 2 autoimmune chronic spontaneous urticaria
-
A practical approach to chronic urticaria
-
A randomized, double-blind, phase 2a study of covalent Bruton’s tyrosine kinase inhibitor TAS5315 in patients with chronic spontaneous urticaria with an inadequate response to H1-antihistamines
-
A rare case of chronic non-bacterial osteomyelitis/chronic recurrent multifocal osteomyelitis (CNO/CRMO) complicated by a Diffuse Large B-Cell Lymphoma (DLBCL)
-
A retrospective analysis of patients with chronic spontaneous urticaria in treatment with Omalizumab conducted in Brescia
-
Acquired chronic granulomatous disease secondary to myelodysplastic disorder
-
Advances in Chronic Urticaria treatment
-
Alteration of the Airway Microbiota is Associated with the Progression of Post-COVID-19 Chronic Cough in Adults
-
Analysis of discontinuation of omalizumab in patients with chronic spontaneous and/or inducible urticaria in a tertiary hospital in one year
-
Anti IgE for the treatment of chronic urticarial
-
Assessing Post-Earthquake Living Conditions and Quality of Life in Chronic Spontaneous Urticaria Patients: Container houses vs. pre-existing buildings
-
Assessing Quality of Life in Chronic Spontaneous Urticaria: Insights from DLQI Scores
-
Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria
-
Assessing the Impact of Dupilumab Treatment on Lung Function in Patients With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
-
Assessment of control in chronic rhinitis and CRS
-
Association between Acinetobacter baumannii-derived extracellular vesicles and chronic urticaria
-
Association of Antinuclear Antibodies with Different Phenotypes of Chronic Urticaria
-
Atopic chronic dermatophytosis syndrome : an observational study to highlight the emergence of an interesting phenomenon
-
Autoimune Chronic Urticaria Preceeding Sisitemic Lupus Erythematous
-
Automation of the Pooled Donor Basophil Activation Test for Chronic Urticaria using the Hamilton STAR: Enhancing Efficiency over the Manual Assay
-
Barzolvolimab Significantly Improves Angioedema in Patients with Chronic Spontaneous Urticaria (CSU): Results from a Phase 2 Trial
-
Basophil Activation Test for Chronic Spontaneous Urticaria: the experience of a paediatric allergy centre
-
Basophil activation test in chronic spontaneous urticaria: a longitudinal assessment
-
Beneficial role of Psychotherapeutic Interventions in Managing Chronic Spontaneous Urticaria Refractory to Omalizumab – A Case Study
-
Benralizumab in Omalizumab refractory chronic spontaneous urticaria – A Case Series of 4 Patients in Portugal
-
Beyond the Rash: How Omalizumab Shapes Mental Health Outcomes in Chronic Spontaneous Urticaria
-
Biologics and rhinosinusitis with and without nasal polyps
-
Biomarkers for Chronic Rhinitis and Rhinosinusitis: Towards Tailored Therapies
-
Biomarkers in chronic spontaneous urticaria
-
Case Study of Chronic Diarrhea Associated with Alterations in the TOM1 Gene
-
Characterization of Treatment-Refractory Chronic Urticaria: A Large-Scale Retrospective Analysis of Clinical and Laboratory Parameters
-
Characterization of pathomechanisms of acute and chronic spontaneous urticaria
-
Chronic Allergen Exposure Induces Accumulation of IgE Plasma Cells in the Lung, Leading to Local IgE Antibody Production
-
Chronic Eosinophilic Sialadenitis Treated Successfully with Dupilumab – A Case Report
-
Chronic Idiopathic Urticaria with the presence of Helicobacter pylori infection-clinical and laboratory data correlation
-
Chronic Mucocutaneous Candidiasis Induced by Inborn Errors of Immunity: A Single-Center Experience
-
Chronic Spontaneous Urticaria Patients in Latvia: Epidemiological and Clinical Characteristics
-
Chronic Urticaria Activity in Patients Treated with Omalizumab at Bellvitge University Hospital (HUB)
-
Chronic Urticaria in Adolescence – An unusual association
-
Chronic Urticaria in Childhood: time for a review
-
Chronic Urticaria: challenges in childhood
-
Chronic hand eczema – updated guidelines
-
Chronic inducible urticaria: classification and prominent features of physical and non-physical types
-
Chronic inflammatory skin diseases and primary atopic disorders
-
Chronic nasal obstruction
-
Chronic rhinosinusitis: from bedside to bench
-
Chronic spontaneous urticaria in Japan: real-world prevalence, treatments and healthcare resource utilisation based on a health insurance database
-
Chronic spontaneous urticaria in children: Series of 10 cases
-
Chronic spontaneous urticaria with wheals, angioedema, or both: Differences in clinical characteristics, biomarkers and treatment response
-
Chronic spontaneous urticaria: latest clinical developments
-
Chronic urticaria across the ages: clinical features, comorbidities, and treatment response
-
Chronic urticaria across the ages: clinical features, comorbidities, and treatment response
-
Chronic urticaria: Natural course, differential diagnosis and comorbidities
-
Clinical Characteristics and Natural Course of Chronic Inducible Urticaria in a Pediatric Cohort
-
Clinical Characteristics of Chronic Urticaria in Adults Under 45 Years Old with Vitamin D Insufficiency
-
Clinical Characteristics, Diagnosis, And Treatment Outcomes In Chronic Cold Urticaria: Insights From A 15-Year Study
-
Clinical aspects of chronic urticaria
-
Clinical perspectives in chronic urticaria: from etiology to severity and prognosis
-
Clinical, Laboratory and Prognostic Evaluation of Antinuclear Antibody Positive and Negative Children with Chronic Urticaria
-
Clinical-laboratory evaluation of children with chronic urticaria
-
Comorbidities of chronic spontaneous urticaria: Do we need to screen and manage them?
-
Comparable Efficacy and Pharmacodynamic Results of CT-P39 to Reference Omalizumab in Patients with Chronic Spontaneous Urticaria
-
Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria
-
Comparison of Component Resolved Diagnosis (CRD) with skin prick test in respiratory allergy [36 cases] and Significance of CRD in Anaphylaxis [8 cases] & Chronic Urticaria with/ without Angioedema [16 cases]
-
Comparison of baseline clinical characteristics of chronic spontaneous urticaria patients receiving omalizumab, with and without concomitant angioedema
-
Concepts and Pathology of Eosinophilic Rhinosinusitis
-
Concomitant allergic and ENT pathology in children with chronic inflammatory diseases
-
Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria
-
Correlation of chronic urticaria and angioedema with the presence of Helicobacter pylori infection
-
Cost Of Illness Analysis of Chronic Urticaria in 5 Latin American Countries: Diagnostic and Therapeutic Expenses
-
Descriptive Study of Chronic Urticaria Under Treatment with Omalizumab: Our Experience
-
Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients
-
Diet modification recommendation for Chronic Spontaneous Urticaria patients -Albanian Allergists approach
-
Difficulties in diagnosing acute and chronic FPIES
-
Do air pollution and weather affect chronic urticaria attack frequency?
-
Dupilumab Improves Type 2 Inflammatory Biomarkers Over Time in Patients With Chronic Obstructive Pulmonary Disease
-
Dupilumab as effective treatment for chronic pruritus: a case report
-
Dupilumab for the treatment of refractory severe chronic spontaneous urticaria
-
EAACI & WAO Joint Symposium : World Allergy Forum – Is the Burden of Chronic Cough Underappreciated in Allergy Practice?
-
Effect of Remibrutinib on Disease Activity in Patients with Chronic Spontaneous Urticaria: Post Hoc Analysis of Phase 3 REMIX-1 and REMIX-2 studies
-
Effect of Remibrutinib on Sleep and Daily Activities in Patients With Chronic Spontaneous Urticaria: Results From the Phase 3 Studies
-
Efficacy and injection schedule adjustment of Dupilumab in patients with chronic rhinosinusitis: Recent experiences in SNUH
-
Efficacy and safety of switching to bilastine, a histamine H1 receptor antagonist, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a phase IV, multicenter, open-label, randomized, parallel-group comparative controlled trial
-
Efficacy and safety of therapy with omalizumab in children with chronic spontaneous urticaria
-
Efficacy of Omalizumab in Food Allergy Management in a Patient with Chronic Spontaneous Urticaria
-
Efficacy of Re-treatment with Omalizumab in Adults with Chronic Spontaneous Urticaria who Relapsed after Treatment Withdrawal
-
Emerging treatments for chronic urticaria
-
Evaluation of Real-World Mental Health and Sleep Outcomes Over Time in US Patients With Chronic Spontaneous Urticaria
-
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease
-
Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab
-
Exploring Drug Hypersensitivity in Pediatric Patients with Chronic Spontaneous Urticaria: ‘’A Comprehensive Analysis Using Diagnostic Tests”
-
Exploring a beta-lactoglobulin-based food for specific medical purposes (FSMP) for dietary management of chronic inflammation in atopic dermatitis: insights from mouse studies
-
Exploring potential predictive factors for time to response to Omalizumab treatment in a Romanian subset of patients with Chronic Spontaneous Urticaria
-
Expression characterization of neuropeptide Y and its receptors in chronic pruritus in psoriasis
-
GRPR/ERK and NPRA/ERK Signaling Pathways Play a Critical Role in Spinal Transmission of Chronic Itch
-
GSK – Refractory Chronic Cough: A Symptom or a Disease?
-
Gain-of-function mutations of human MRGPRX2 in the Chronic spontaneous urticaria
-
Hereditary angioedema and severe chronic urticaria, what the odds?
-
Hidden parasitic causes in chronic spontaneous urticaria
-
Hives and hidden codes: detection of miRNA in chronic spontaneous urticaria patients – pilot study
-
How can we improve the approach to treating chronic urticaria in children?
-
Hypoallergenic and anti-remodeling effect of a hybrid protein in a murine model of chronic asthma induced by Dermatophagoides pteronyssinus
-
IgE and Eosinophils levels may predict Successful Omalizumab withdrawal in chronic spontaneous urticaria
-
IgE anti-TPO; from acute to chronic urticaria
-
IgG and IgE autoantibodies in chronic spontaneous urticaria
-
Impact of Age and Allergen Type on Sensitization Changes in Chronic Rhinitis Children
-
Impact of asthma as a chronic disease on the quality of life of the patient and his family
-
Impact of chronic inducible urticaria (CIndU) on patients’ health-related quality of life: Results from Urticaria Voices study
-
Impaired Retinoic Acid Metabolism and Eotaxin Overexpression in Eosinophilic Chronic Rhinosinusitis: Insights into Pathophysiology and Therapeutic Potential of CRABP1 Targeting
-
Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
-
Incidence of allergic rhinitis in different age group rhinosinusitis
-
Increased eosinophil-derived neurotoxin levels in serum of chronic spontaneous urticaria patients
-
Infection History and Risk of Chronic Inflammatory Airway Diseases; A Real-World Hospital Cohort Study
-
Infection History and Risk of Chronic Inflammatory Airway Diseases; A Real-World Hospital Cohort Study
-
Initial Results from SPOTLIGHT, a Phase 1b/2a Dose Escalation Study of the anti-c-Kit Briquilimab Antibody in Adults with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite H1-Antihistamine Treatment
-
Is it possible to use the platelet and neutrophil lymphocyte ratios and systemic immune inflammation index as potential biomarkers for chronic urticaria?
-
Knowledge and satisfaction about the use of Patient Reported Outcomes Measures (PROMs) by patients with chronic urticaria
-
Knowledge, attitudes and practice patterns in chronic spontaneous urticaria management among Italian General Practitioners: Baseline data from the BRIDGE implementation science study
-
LAD2 Mast Cell Activation Test in Chronic Spontaneous Urticaria
-
Late Presentation of Cutaneous Chronic Graft Versus Host Disease – A Case Report
-
Lessons Learned from the Diagnosis and Management of a female pediatric patient with NCF2 Mutations and Chronic Granulomatous Disease
-
Linguistic Adaptation of Urticaria Activity Score Over 7 Days (UAS7) to Latvian: Evaluating Disease Activity in Adult Patients with Chronic Spontaneous Urticaria in Latvia
-
Long-Term Efficacy and Safety of Remibrutinib in Patients with Chronic Spontaneous Urticaria in the Phase 3 REMIX-1 and REMIX-2 Studies
-
MOLECULAR IgE SENSITIZATION PROFILE IN A PATIENT WITH ADULT ATOPIC DERMATITIS AND CHRONIC URTICARIA SYNDROME TO FOODS
-
MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin
-
Management chronic urticaria in children
-
Management of Chronic Spontaneous Urticaria and Atopic Dermatitis with Omalizumab: A Case Report Highlighting Efficacy and Emerging Challenges
-
Microglia–Neuron Interactions Promote Chronic Itch via the NLRP3-IL-1β-GRPR Axis
-
Minimal persistent inflammation in chronic spontaneous urticaria patients with clinical remission
-
Nature Prescription: Another Alternative Therapy for Patients with Chronic Respiratory Disease – Pilot Study
-
New players in chronic urticaria
-
Next generation sequencing analysis in H1-antihistamine-refractory chronic spontaneous urticaria
-
Omalizumab and chronic spontaneous urticaria: ‘one dose does not fit all’
-
Optimizing Omalizumab Therapy in Chronic Urticaria: Tailored Approaches for Weaning and Sustained Remission
-
Paradoxical urticaria to H1-antihistamines in a patient with chronic spontaneous urticaria
-
Phenotypic Clusters of Patients with Severe Chronic Spontaneous Urticaria
-
Physicians’ prescribing patterns and perceptions of treatments for chronic spontaneous urticaria: Real world data from Urticaria Voices
-
Polyethylene glycol sensitization in patients with chronic lower extremity dermatitis: Question the use of nitrofurazone twice!
-
Practical applications of ‘omics’ in chronic airway disease
-
Predicting Responses to Omalizumab in Antihistamine-Refractory Chronic Urticaria
-
Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients
-
Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients
-
Prevalence and characteristics of local allergic rhinitis to American cockroach in chronic rhinitis
-
Prevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases is Increasing in Korean Children and Adolescents
-
Quality of life of families with children suffering from chronic urticaria
-
Re-evaluation of the role of drugs in the occurrence of chronic eczematiform eruptions in elderly by comparison with data from the French National Health Data System in the french general population
-
Real world long-term data effectiveness of rupatadine in chronic urticaria: retrospective, monocentric, observational study
-
Real-World Evaluation of Omalizumab in Chronic Spontaneous and Inducible Urticaria: A Longitudinal Analysis during 15 years from a Lisbon UCARE
-
Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria
-
Reduction in Weekly Urticaria Activity Score (UAS7) With Rilzabrutinib in Patients With Chronic Spontaneous Urticaria: 12-Week Results From the RILECSU Phase 2 Dose-Ranging Study
-
Refractory Chronic Cough: A Symptom or a Disease?
-
Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria
-
Remibrutinib demonstrates sustained control of angioedema in patients with chronic spontaneous urticaria: 52-week treatment results from the phase 3 REMIX studies
-
Remibrutinib improves chronic spontaneous urticaria independent of baseline immunoglobulin E levels in the phase 3 REMIX studies
-
Retrospective study of the effect of bacterial immunotheraphy on patients with chronic respiratory diseases
-
Rhinosinusitis
-
Rilzabrutinib Reduces IgG Anti-Thyroid Peroxidase (anti-TPO), Soluble Mas-Related G Protein-Coupled Receptor X2 (sMRGPRX2) and Eosinophils at 12 Weeks in Patients With Chronic Spontaneous Urticaria
-
Rilzabrutinib Results in Rapid Improvement of Symptoms in Patients With Chronic Spontaneous Urticaria: Results From the RILECSU Phase 2 Dose-Ranging Study
-
SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria
-
SPOTLIGHT: A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihis
-
Safety of Remibrutinib in Patients With Chronic Spontaneous Urticaria: Results From the Phase 3 REMIX-1 and REMIX-2 Studies
-
Sensitization to three species of mites in patients with chronic rhinitis in a tropical region of Latin America
-
Serum Cytokine Profiles in Chronic Spontaneous Urticaria: Correlations with Disease Severity, Endotypes, and Autoreactivity
-
Sleep disturbance is a significant mediator between active disease and impaired work productivity in patients with chronic urticaria: Findings from a causal mediation analysis
-
Smoking increases mortality risk of chronic inflammatory airway diseases: a real-world hospital cohort study
-
Spinal GRPR and NPRA contribute to chronic itch in a murine model of allergic contact dermatitis
-
Successful administration of omalizumab following anaphylaxis in a patient with chronic idiophatic urticaria
-
Successful desensitization to nilotinib after imatinib-induced Sweet’s syndrome and nilotinib hypersensitivity reaction in a patient with chronic myeloid leukemia
-
Systemic Histaminergic Findings in Children with Chronic Urticaria
-
Systemic steroids in chronic rhinosinusitis: no risk no fun?
-
Taking a closer look to the first EMA-approved omalizumab biosimilar in Chronic Spontaneous Urticaria
-
The BEACON Study: A Phase 1b/2a, Dose Escalation Study of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of the c-Kit Mab Briquilimab in Adults with symptomatic Chronic Spontaneous Urticaria (CSU)
-
The UCARE Study on the Prevalence of Sleep Disorders and Nighttime Bruxism in People with Chronic Urticaria
-
The Urticaria Voices study: Experiences and unmet needs of patients with chronic inducible urticaria (CIndU)
-
The association between baseline IgE levels and response to standard-dose omalizumab in uncontrolled chronic urticaria patients
-
The association between baseline IgE levels and response to standard-dose omalizumab in uncontrolled chronic urticaria patients
-
The autologous serum skin test (ASST) predicts the response to anti-IgE treatment in Chronic Spontaneous Urticaria patients: a prospective study
-
The challenge of chronic urticaria management
-
The characteristics of Chronic Inducible Urticaria in Cape Town, South Africa
-
The effects of environmental factors on incidences of allergic rhinitis and chronic rhinosinusitis: a comparative study
-
Topical steroids in infants and childen with chronic eczema.
-
Treating chronic inflammation in the upper airways
-
Treatment of Chronic Spontaneous Urticaria with Omalizumab Complicated by Onychodystrophy?
-
Treatment of Chronic Spontaneous Urticaria with Omalizumab during Pregnancy- Experience in a Portuguese Ucare
-
Treatment with Barzolvolimab Leads to Sustained Improvement in Angioedema in Chronic Spontaneous Urticaria (CSU) patients: Results from 52 Weeks of Treatment
-
Unraveling the Mysteries of Chronic Granulomatous Disease: A Case of detected Protein Deficiency Amidst Negative Genetic Screening
-
Update on chronic inducible urticaria
-
Urticaria activity, quality of life and disease control in chronic spontaneous urticaria patients in Kazakhstan
-
Urticaria exacerbations in children with chronic urticaria receiving COVID-19 vaccination
-
Use of nasal irrigation as add on therapy to non responders to pharmacotherapy in chronic adenoiditis
-
What can we now do for chronic cough?
-
What to examine when you consider chronic urticaria
-
What’s new in chronic urticaria management?
-
When Antihistamines Paradoxically Worsen Chronic Spontaneous Urticaria: Trust Your Patient
-
World Allergy Forum – Is the Burden of Chronic Cough Underappreciated in Allergy Practice?
-
Worldwide experiences and unmet needs of patients with chronic spontaneous urticaria and treating physicians: The Urticaria Voices study
-
Аnti-inflammatory effect of extracorporeal shock wave therapy as treatment for chronic calculous prostatitis
-
A Regulatory Risk haplotype in HLA-DQ region regulates antigen presentation of monocyte in Type 2 inflammation in chronic rhinosinusitis with nasal polyps
-
A Systematic Review of Multidimensional Predictors for Refractory Chronic Rhinosinusitis
-
A comparative analysis of pediatric and adult endotypes of chronic rhinosinusitis
-
A patient-centric approach to chronic rhinosinusitis with nasal polyps (CRSwNP): developing tools to improve disease management and outcomes
-
A predictive model to differenciate chronic histaminergic angiodema and chronic spontaneous urticaria with angioedema
-
A predictive model to differenciate chronic histaminergic angiodema and chronic spontaneous urticaria with angioedema
-
A step towards standardized Clinical Remission Criteria for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): insights from a real-life study
-
ANCHOR-1 and 2 Study Design: Replicate Phase 3 Randomised, Double-Blind, Placebo-Controlled Studies of the Efficacy and Safety of Depemokimab in Patients with Chronic Rhinosinusitis with Nasal Polyps
-
Advancements and Key Insights in Chronic Rhinosinusitis (CRS) Management
-
Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)
-
Anti-thymic stromal lymphopoietin CM326 for uncontrolled chronic rhinosinusitis with nasal polyps: a randomized, double-blind, placebo-controlled phase 1b/2a trial
-
Artificial intelligence-assisted prediction of olfactory disorders in patients with chronic rhinosinusitis
-
Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry
-
Challenges in Biologics for Chronic Rhinosinusitis with Nasal Polyps
-
Changes in pathological characteristics and influence factors of chronic rhinosinusitis in the Greater Bay Area of China: A retrospective study on whole slide image-based of artificial intelligence
-
Characteristics of patients with chronic rhinosinusitis with nasal polyps and allergic rhinitis enrolled in the global AROMA registry
-
Characterization of chronic rhinosinusitis patients based on markers of type 2 inflammation: Findings from the European CRS Outcome Registry (CHRINOSOR)
-
Characterizing chronic histaminergic angioedema and chronic urticaria with angioedema, a multicenter Italian experience
-
Chronic Rhinosinusitis
-
Chronic rhinosinusitis among young adults is strongly associated with atopy and signs of type-1 inflammation
-
Chronic rhinosinusitis with nasal polyposis: an old problem with a new solution
-
Clinical Implication of Neutrophil Phenotypes in Chronic Rhinosinusitis With Nasal Polyps
-
Clinical and Treatment Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps by Treating Physician Specialty: Results from an EU Chart Review Study
-
Construction of prediction model for olfactory dysfunction improvement in patient with chronic rhinosinusitis after endoscopic sinus surgery
-
CosMx™ single cell spatial imaging identifies changes in spatial cell communication in chronic rhinosinusitis with nasal polyps following anti – IL-5 treatment
-
Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry
-
Demographic and Laboratory Differences Between Chronic Spontaneous and Chronic Inducible Urticaria: Insights from a Lisbon UCARE
-
Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of tezepelumab in adult patients with severe chronic rhinosinusitis with nasal polyposis (WAYPOINT)
-
Determinants of Adherence of Biologic Therapies in Chronic Rhinosinusitis
-
Distribution of Baseline Type 2 Inflammation Characteristics in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Biologic Clinical Trials: A Comparative Assessment
-
Doxycycline therapy reduced local nasal inflammation and promoted wound healing after FESS in Chronic Rhinosinusitis patients
-
Dual monoclonal antibody therapy in a patient with chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma: a case report and proteome analysis
-
Dupilumab Restores Barrier Function of Nasal Epithelial Cells and Decreases Type-2 Inflammatory Markers in Chronic Rhinosinusitis with Nasal Polyps
-
Dupilumab Treatment is Associated with Clinical Improvement and a Shift towards a health-associated Nasal Passage Microbiota in Diffuse Type 2 Chronic Rhinosinusitis
-
Dupilumab alleviates the abnormal differentiation of club cells induced by IL-13 in chronic rhinosinusitis with nasal polyps
-
Dupilumab-induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis
-
Dupilumab-induced skin reaction in a patient with severe asthma and chronic rhinosinusitis with nasal polyposis and without prior skin conditions
-
Early Responders within One Month of Dupilumab Treatment for Chronic Rhinosinusitis with Nasal Polyps
-
Effect of Dupilumab on Radiological Remission in Patients with Chronic Rhinosinusitis with Nasal Polyp: A step Toward Clinical Remission
-
Effect of anti IL-5/IL-5Rα biological treatment on tissue eosinophil subpopulations in patients affected by Chronic Rhinosinusitis with Nasal Polyp
-
Effectiveness and Safety of Dupilumab in patients with chronic rhinosinusitis with nasal polyps After One Year of Therapy: Results from a real-world non-interventional study in Germany (ProGNOSE)
-
Effects of Dupilumab on Eosinophil Subpopulations and Inflammation in Chronic Rhinosinusitis with Nasal Polyps
-
Efficacy and safety of tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps overall and in patients with and without co-morbid asthma: results from the phase 3 WAYPOINT study
-
Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps
-
Efficacy of Omalizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps and Association with Local Immunoglobulin E
-
Emerging Biologic Use May Reduce the Need for Corticosteroid Treatment and Surgery for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in France, Germany, Italy, Spain and the UK
-
Endotyping chronic rhinosinusitis for a better treatment approach
-
Enhanced Production of CEACAM5 And Its Association With Increased Plasma Cell Infiltration In Chronic Rhinosinusitis With Nasal Polyps
-
Eosinophilic Chronic Rhinosinusitis with Nasal Polyps : Current Perspective
-
Evaluating ChatGPT’s Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis
-
Evaluation of Early Real-World Efficacy and Safety of Mepolizumab in Chronic Rhinosinusitis with Nasal Polyposis Through a Multidisciplinary Approach
-
Features of chronic spontaneous urticaria in patients with atopic comorbidities: Results from CURE, the chronic urticaria registry
-
Frequency and impact of chronic rhinosinusitis on allergic rhinitis: a retrospective multicenter cohort study with long term follow-up
-
Hippo-YAP inhibits the autophagic degradation of Cyclin D1 in chronic rhinosinusitis with nasal polyps
-
Improved Quality of Life, Early Symptom Control and Reduced Surgery with Mepolizumab in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): Results from the SYNAPSE Study
-
Improvement in Olfactory Training for Postoperative Olfactory Dysfunction in Chronic Rhinosinusitis with Nasal Polyps
-
Initiation of dupilumab led to reduced use of corticosteroids and antibiotics over 12 months in patients with chronic rhinosinusitis with nasal polyps treated in US real world practice
-
Inotodiol attenuates mucosal inflammation in a mouse model of eosinophilic chronic rhinosinusitis
-
Is Chronic Rhinosinusitis Still an Underestimated Disease?
-
Local nasal inflammation and postoperative wound healing is improved by postoperative doxycycline therapy after FESS in Chronic Rhinosinusitis patients
-
Longitudinal Assessment of Dupilumab’s Therapeutic Effects in Chronic Rhinosinusitis with Nasal Polyps
-
Mental health, sexual functionality, quality of life, and patient experiences with chronic rhinosinusitis with nasal polyps at UNIMEQ-ORL in Bogotá, Colombia, 2022-2024: a mixed-methods study
-
Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology
-
Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology
-
Nasal microbiome in chronic rhinosinusitis
-
Nasal polyp CD62Llow eosinophils as a prognostic biomarker of chronic rhinosinusitis with nasal polyp severity and predictive biomarker of mepolizumab and dupilumab response
-
Outcomes in chronic rhinosinusitis and type 2 inflammation
-
PROMs Improvement Effects of Biologics in Chronic Rhinosinusitis with Nasal Polyps Patients: Real-life Experience
-
Pathological Characteristics of Chronic Rhinosinusitis and Their Association with Urbanization: A Retrospective Study Based on Whole-Slide Scanning Using Artificial Intelligence
-
Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma Experience Early and Sustained Benefit with Depemokimab in the Randomised, Double-Blind, Parallel-Group, Replicate ANCHOR-1/2 Studies
-
Performance of 5 item and 22 item sino-nasal outcome tests in response to dupilumab in chronic rhinosinusitis with nasal polyps
-
Phenotypes and inflammatory molecular endotypes of chronic rhinosinusitis and its implication for asthma
-
Platycodon D protects human nasal epithelial cells from pyroptosis through the Nrf2/HO-1/ROS signaling cascade in chronic rhinosinusitis
-
Postoperative Anti-IgE Therapy for Chronic Rhinosinusitis with Nasal Polyps and Asthma: Efficacy and Prognostic Factors
-
Predictive model for postoperative unrecovered olfactory function in chronic rhinosinusitis patients with olfactory disorder
-
Proteomic analysis identifies patients with chronic rhinosinusitis with nasal polyps who are responders and non-responders to benralizumab (NAPPREB study)
-
REALITI-N: First Ambidirectional Cohort Study Evaluating Real-World Mepolizumab Use in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
-
Real-Life Effectiveness of Mepolizumab and Omalizumab in Sever Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Prospective Study
-
Real-Life Effectiveness of Monoclonal Antibody Therapy in Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Prospective Study
-
Real-Life effectiveness of a Cohort of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) and Concomitant Moderate Persistent Asthma Treated with Dupilumab
-
Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
-
Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
-
Real-world effectiveness of dupilumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) is independent of comorbidities, sinus surgery history and level of type 2 inflammation: Findings from CHRINOSOR
-
Regulatory T cells act as the guardians of mucosal immune homeostasis in chronic rhinosinusitis
-
SLC27A2 marks lipid peroxidation in nasal epithelial cells driven by type 2 inflammation in chronic rhinosinusitis with nasal polyps
-
SNOT-22 and olfactory perception in Chronic Rhinosinusitis with Nasal Polyps: A Retrospective Observational Study
-
Sequence of improvements in objective and patient-reported outcomes with dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: Analysis of the SINUS-52 study
-
Stapokibart for severe uncontrolled chronic rhinosinusitis with nasal polyps: multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 trial
-
Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment
-
Tezepelumab reduces OCS use and improves sino-nasal symptoms in OCS-dependent patients with severe asthma and comorbid chronic rhinosinusitis (overall and with nasal polyps): results from the phase 3b WAYFINDER study
-
The Clinical Characteristics and Inflammatory Endotypes of Chronic Rhinosinusitis with Nasal Polyps in Southern China: A Multi-Center, Cross Section study
-
The Influence of Dupilumab on the Nasal and Gastrointestinal Microbiome in Diffuse Type 2 Chronic Rhinosinusitis
-
The Relationship Between Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Serum Mas-Related G-Protein Coupled Receptor-X2 (MRGPRX2) Level
-
The Role of Rho GTPase Signaling on Epithelial-Mesenchymal Transition and Inflammation of Chronic Rhinosinusitis with Nasal Polyp
-
The impact of intranasal corticosteroids on exhaled nitric oxide in chronic eosinophilic rhinosinusitis with nasal polyposis after surgery
-
The impact of secretory IgA on nasal microbiome control and its link to the development of chronic rhinosinusitis
-
The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
-
The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
-
The role of anosmia in predicting biologic responsiveness for Chronic Rhinosinusitis with Nasal Polyposis
-
The upper airway microbiome – potential target in chronic rhinosinusitis
-
Understanding and managing Chronic Rhinosinusitis with Nasal Polyps
-
Unveiling the Prevalence and Impact of Silent Rhinovirus Infection in Chronic Rhinosinusitis with Nasal Polyps
-
Correlation of chronic rhinosinusitis and lung function in allergy patients with chronic cough
-
The correlation between chronic rhinosinusitis with/without nasal polyp and chronic kidney disease: a longitudinal follow-up study
Show more Sessions (304)Show Less-